It is the most common side effect by a wide margin, and it typically follows a predictable pattern
This age-related muscle loss called sarcopenia is associated with: Weakness Slower metabolism Poor balance Fat gain Reduced longevity Frailty Reduced recovery MOTS-c is being researched for its possible influence on: Skeletal muscle metabolism Exercise adaptation Mitochondrial biogenesis Cellular stress resilience Some animal studies demonstrated improved: Physical performance Exercise endurance Metabolic adaptation This has made MOTS-c especially interesting in: Longevity medicine Sports medicine Functional fitness Healthy aging protocols MOTS-c for Athletic Performance & Recovery Could MOTS-c become the future of mitochondrial performance optimization
Patients who want bundled coaching, branded GLP-1s, or a self-serve cancel button should look elsewhere
In this study, twice-daily exenatide treatment was associated with a lower risk of CVD events including MI, ischemic stroke, or coronary revascularization procedure (hazard ratio [HR], 0.81
Berberine, dietary fibre, and omega-3 fatty acids have preliminary evidence for modest effects on GLP-1 secretion, but human studies are limited
